Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2022-06-18 2022-06-17
Drug Identification Number 02244854 02244854
Brand name MILRINONE LACTATE INJECTION MILRINONE LACTATE INJECTION
Common or Proper name MILRINONE LACTATE MILRINONE LACTATE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients MILRINONE MILRINONE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 vials X 10 mL 10 vials X 10 mL
ATC code C01CE C01CE
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-06-17 2022-06-17
Remaining supply date 2022-06-17 2022-06-17
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments